SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Marksans Pharma shines on successful completion of inspection

20 Feb 2017 Evaluate

Marksans Pharma is currently trading at Rs. 48.50, up by 7.90 points or 19.46% from its previous closing of Rs. 40.60 on the BSE.

The scrip opened at Rs. 41.65 and has touched a high and low of Rs. 48.70 and Rs. 41.65 respectively. So far 9089744 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 58.30 on 06-Oct-2016 and a 52 week low of Rs. 33.45 on 01-Mar-2016.

Last one week high and low of the scrip stood at Rs. 48.70 and Rs. 37.10 respectively. The current market cap of the company is Rs. 1983.12 crore.

The promoters holding in the company stood at 48.25%, while Institutions and Non-Institutions held 14.54% and 37.21% respectively.

Marksans Pharma's Goa plant has had an inspection by UK MHRA from February 14, 2017 to February 17, 2017 and it is located at L-82 & L-83, Verna Industrial Estate in Goa. The same has been completed without any critical observations. The company is awaiting further instruction from the agency in this regard.

Marksans Pharma is engaged in production of prescription drugs, caters in areas like oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynaecology and others.

Marksans Pharma Share Price

193.90 0.85 (0.44%)
24-Apr-2026 09:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1648.00
Dr. Reddys Lab 1323.20
Cipla 1289.70
Zydus Lifesciences 937.70
Lupin 2330.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×